Analysis of the p53 tumor suppressor gene by pyrosequencing

被引:40
作者
Ahmadian, A [1 ]
Lundeberg, J [1 ]
Nyrén, P [1 ]
Uhlén, M [1 ]
Ronaghi, M [1 ]
机构
[1] Royal Inst Technol, Stockholm, Sweden
关键词
D O I
10.2144/00281rr02
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor genes are implicated in cell cycle progression. Inactivation of these genes predominantly occurs through mutations and/or allelic loss that involves both alleles. With inactivation by multiple mutations in a single gene, cloning of the amplified gene is necessary to determine whether the mutations reside on one ol both alleles. Using pyrosequencing, a recently developed approach based on sequencing-by-synthesis, we studied genetic variability in the p53 tumor suppressor gene and could quantify the ratio between the mutated and wild-type amplified fragments. Further-more, this sequencing technique also allows allelic determination of adjacent mutations with no cloning of amplified fragments.
引用
收藏
页码:140 / +
页数:6
相关论文
共 17 条
[1]  
BERG C, 1995, CLIN CHEM, V41, P1461
[2]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[3]   P53 - AT THE CROSSROADS OF MOLECULAR CARCINOGENESIS AND RISK ASSESSMENT [J].
HARRIS, CC .
SCIENCE, 1993, 262 (5142) :1980-1981
[4]  
HEDRUM A, 1994, BIOTECHNIQUES, V17, P118
[5]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[6]   DIRECT SOLID-PHASE SEQUENCING OF GENOMIC AND PLASMID DNA USING MAGNETIC BEADS AS SOLID SUPPORT [J].
HULTMAN, T ;
STAHL, S ;
HORNES, E ;
UHLEN, M .
NUCLEIC ACIDS RESEARCH, 1989, 17 (13) :4937-4946
[7]   Production, purification, and luminometric analysis of recombinant Saccharomyces cerevisiae MET3 adenosine triphosphate sulfurylase expressed in Escherichia coli [J].
Karamohamed, S ;
Nilsson, J ;
Nourizad, K ;
Ronaghi, M ;
Pettersson, B ;
Nyrén, P .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 15 (03) :381-388
[9]   Molecular pathology in basal cell cancer with p53 as a genetic marker [J].
Ponten, F ;
Berg, C ;
Ahmadian, A ;
Ren, ZP ;
Nister, M ;
Lundeberg, J ;
Uhlen, M ;
Ponten, J .
ONCOGENE, 1997, 15 (09) :1059-1067
[10]  
Ren ZP, 1996, ONCOGENE, V12, P765